Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Authors: Samuel Seidu, Setor K. Kunutsor, Howard D. Sesso, J. M. Gaziano, J. E. Buring, Maria Carla Roncaglioni, Kamlesh Khunti

Published: 2019-06-03

DOI: 10.1186/s12933-019-0875-4

Source: Full article


Abstract

Abstract